Tech Company Financing Transactions
OsteoGeneX Funding Round
OsteoGeneX closed a Seed funding round on 11/21/2014. Backers included Lumira Capital and private investors.
Transaction Overview
Company Name
Announced On
11/21/2014
Transaction Type
Venture Equity
Amount
Unknown
Round
Seed
Investors
Lumira Capital (Lead Investor) (Daniel Hetu)
Proceeds Purpose
This financing round enables us to rapidly advance our lead small molecule product candidate for bone formation.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
11235 Mastin St. 102
Overland Park, KS 66210
USA
Overland Park, KS 66210
USA
Phone
Website
Email Address
Overview
OsteoGeneX is committed to leveraging its innovative signaling pathway technologies to discover and develop small molecule therapeutics that are focused primarily on building new bone.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Debra Ellies
Chief Marketing Officer
William Rosenberg
VP - Bus. Development
Michael Riley
VP - General Counsel
Bruce Jenett
Browse more venture capital transactions:
Prev: 11/20/2014: ImThera Medical venture capital transaction
Next: 11/21/2014: SimplyTapp venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. All VC database entries reported here come from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs